BioCentury
ARTICLE | Emerging Company Profile

moksha8: Racing into emerging markets

April 28, 2008 7:00 AM UTC

Despite attractive growth in emerging markets such as Brazil, Asia, Eastern Europe and the Middle East, many pharma companies and large biotechs lack the wherewithal or incentive to market their own drugs in these regions, and local players often lack the sophistication to do it.

moksha8 Pharmaceuticals Inc. hopes to establish itself as a "one-stop shop" commercialization partner for pharma companies and large biotechs that wish to tap these emerging markets. The company's business model is to obtain commercialization rights to high-quality drugs, including products already marketed by big pharma or best-in-class therapeutics from big biotech or mid-size pharmas, according to CEO Simba Gill...